No price history available.
Key financial summary
Financials in KRW| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | KRWm | 4,890,151 | 5,410,415 | 5,659,922 | 5,894,231 | 6,028,364 | 5,821,815 | N/A | N/A |
| Operating profit | KRWm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | KRWm | 149,253 | 128,377 | 159,880 | 8,566 | 170,309 | -158,472 | N/A | N/A |
| EPS reported | KRW | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | KRW | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | KRW | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | KRW | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | KRWm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | KRWm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | KRWm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | KRW | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | KRW | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in KRW| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Founded in Gwacheon, South Korea, in 1957, Kolon Corporation operates as a diversified enterprise, primarily supporting and managing its affiliated businesses. Its operations extend to intellectual property licensing, market research, and management consulting, serving both domestic and international markets. The company manufactures a comprehensive range of industrial and chemical products. These include tire cords, airbags, polyester spunbond, technical yarns, aramid products, and various films such as polyester, nylon, and coated films. It also produces DFR materials, overcoats, beads, hydrocarbon, phenolic, and epoxy resins, along with PU/TPU products and glass-reinforced plastic pipes. Additionally, Kolon supplies nylon and polyester fibers, as well as woven, knit, and high-performance functional fabrics. Beyond manufacturing, Kolon is active in commodity trading, dealing in steel, natural resources, and chemicals. Its construction division undertakes residential, industrial plant, civil engineering, and environmental projects. The company also specializes in automotive components, fabricating car seat modules, fabrics, and car mats. Furthermore, it develops specialty fibers like artificial turfs, polypropylene staple fibers, Bicomponent staple fiber, GEONIC, Cuprus, HeaTex, and polyester filaments. Kolon maintains a significant presence in the pharmaceutical and healthcare sectors. It offers over-the-counter medicines, the TRAMOL sustained relief painkiller and anti-inflammatory, active pharmaceutical ingredients, and biopharmaceuticals such as Tissuegene. The company also manages approximately 150 drugstores under the W-Store brand. In real estate and hospitality, Kolon develops properties and manages hotels, condominiums, and golf resorts. Its leisure operations include a shopping mall, a pet theme park, and themed toilets. Further diversifying its portfolio, Kolon operates Sweet Meal cafés, serving pastries, coffee, cheesecakes, and beverages. It supplies antimicrobial products, various PA, PBT, and POM base and compound resins, and retails both hardware and software. The company also delivers IT and business process outsourcing, alongside IT convergence services. Finally, Kolon is deeply involved in water-related environmental businesses, covering sewage and wastewater treatment, including the provision of materials, systems, equipment, and the operation of water treatment facilities. It also runs an industrial supply retail operation.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Kolon Corporation (002020.KS)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Founded in Gwacheon, South Korea, in 1957, Kolon Corporation operates as a diversified enterprise, primarily supporting and managing its affiliated businesses. Its operations extend to intellectual property licensing, market research, and management consulting, serving both domestic and international markets. The company manufactures a comprehensive range of industrial and chemical products. These include tire cords, airbags, polyester spunbond, technical yarns, aramid products, and various films such as polyester, nylon, and coated films. It also produces DFR materials, overcoats, beads, hydrocarbon, phenolic, and epoxy resins, along with PU/TPU products and glass-reinforced plastic pipes. Additionally, Kolon supplies nylon and polyester fibers, as well as woven, knit, and high-performance functional fabrics. Beyond manufacturing, Kolon is active in commodity trading, dealing in steel, natural resources, and chemicals. Its construction division undertakes residential, industrial plant, civil engineering, and environmental projects. The company also specializes in automotive components, fabricating car seat modules, fabrics, and car mats. Furthermore, it develops specialty fibers like artificial turfs, polypropylene staple fibers, Bicomponent staple fiber, GEONIC, Cuprus, HeaTex, and polyester filaments. Kolon maintains a significant presence in the pharmaceutical and healthcare sectors. It offers over-the-counter medicines, the TRAMOL sustained relief painkiller and anti-inflammatory, active pharmaceutical ingredients, and biopharmaceuticals such as Tissuegene. The company also manages approximately 150 drugstores under the W-Store brand. In real estate and hospitality, Kolon develops properties and manages hotels, condominiums, and golf resorts. Its leisure operations include a shopping mall, a pet theme park, and themed toilets. Further diversifying its portfolio, Kolon operates Sweet Meal cafés, serving pastries, coffee, cheesecakes, and beverages. It supplies antimicrobial products, various PA, PBT, and POM base and compound resins, and retails both hardware and software. The company also delivers IT and business process outsourcing, alongside IT convergence services. Finally, Kolon is deeply involved in water-related environmental businesses, covering sewage and wastewater treatment, including the provision of materials, systems, equipment, and the operation of water treatment facilities. It also runs an industrial supply retail operation.
